HKD 3.58
(-0.56%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 7.66 Million USD | -14.87% |
2022 | 9 Million USD | 58.15% |
2021 | 5.69 Million USD | 133.55% |
2020 | 2.43 Million USD | 50.77% |
2019 | 1.61 Million USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 383 Thousand USD | 0.0% |
2024 Q1 | 383 Thousand USD | 0.0% |
2023 FY | 7.66 Million USD | -14.87% |
2023 Q2 | 7.91 Million USD | -78.9% |
2023 Q1 | 37.49 Million USD | 316.35% |
2023 Q4 | 7.66 Million USD | -79.99% |
2023 Q3 | 38.31 Million USD | 384.29% |
2022 Q2 | 6.97 Million USD | -71.42% |
2022 Q1 | 24.38 Million USD | 328.24% |
2022 FY | 9 Million USD | 58.15% |
2022 Q4 | 9 Million USD | -76.39% |
2022 Q3 | 38.14 Million USD | 447.26% |
2021 Q3 | 3.62 Million USD | 0.0% |
2021 FY | 5.69 Million USD | 133.55% |
2021 Q4 | 5.69 Million USD | 56.9% |
2021 Q1 | - USD | -100.0% |
2020 Q4 | 2.43 Million USD | 0.0% |
2020 FY | 2.43 Million USD | 50.77% |
2019 FY | 1.61 Million USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | 30.61 Million HKD | 74.958% |
CK Life Sciences Int'l., (Holdings) Inc. | 4.27 Billion HKD | 99.821% |